Literature DB >> 11591020

Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers.

J Dunst1, P Stadler, A Becker, T Kuhnt, C Lautenschläger, M Molls, G Haensgen.   

Abstract

BACKGROUND: Hypoxia is the most important stimulus for the up-regulation of vascular endothelial growth factor (VEGF), one of the key cytokines for angiogenesis. We have investigated the possible relationship between tumor hypoxia and systemic levels of VEGF. PATIENTS AND METHODS: 56 patients with head and neck cancers underwent measurement of tumor volume (pretreatment CT scans), tumor oxygenation (pO2 histography) and serum levels of VEGF. The hemoglobin level ranged from 9.1 to 16 g/dl. The absolute amount of hypoxic tumor (hypoxic tumor volume) was determined as the product of the absolute tumor volume and the relative frequency of hypoxic (< 5 mm Hg) measurements in the pO2 histography.
RESULTS: The serum VEGF levels in the 56 head and neck cancer patients ranged from 102 to 1699 pg/ml (median 405 pg/ml, mean 527 +/- 396 pg/ml). Elevated serum-VEGF levels (> 700 pg/ml) were found in 14/56 patients (25%). Serum-levels of VEGF were significantly and independently correlated with hypoxic tumor volume (R2 = 0.63, p < 0.001), but also with total tumor volume, hemoglobin levels, platelet counts and tumor hypoxia. There was no correlation with T and N category, histological grading, and age.
CONCLUSIONS: The strong and independent impact of the hypoxic tumor volume on systemic VEGF levels suggests that the absolute amount of hypoxia within a tumor represents the most important stimulus for up-regulation of angiogenesis. Anemia acts as a co-factor via worsening of tumor tissue oxygenation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591020     DOI: 10.1007/pl00002428

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  16 in total

Review 1.  Hyperbaric oxygen therapy for malignancy: a review.

Authors:  Jurstine Daruwalla; Chris Christophi
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

2.  Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.

Authors:  Wei-Jian Guo; Jie Li; Wan-Long Ling; Yong-Rui Bai; Wen-Zhu Zhang; Yu-Fan Cheng; Wen-Hua Gu; Jun-Yan Zhuang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  Pleiotrophic actions of erythropoietin.

Authors:  Laurie Feldman; Arthur J Sytkowski
Journal:  Environ Health Prev Med       Date:  2003-01       Impact factor: 3.674

4.  A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.

Authors:  C Ostheimer; M Bache; A Güttler; M Kotzsch; D Vordermark
Journal:  Strahlenther Onkol       Date:  2013-12-11       Impact factor: 3.621

5.  Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck.

Authors:  Bijan Khademi; Mehdi Soleimanpour; Abbas Ghaderi; Mohammad Mohammadianpanah
Journal:  Oral Maxillofac Surg       Date:  2013-03-03

Review 6.  Clinical biomarkers for hypoxia targeting.

Authors:  Quynh-Thu Le; Don Courter
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

Review 7.  New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.

Authors:  Nancy Y Lee; Quynh-Thu Le
Journal:  Semin Oncol       Date:  2008-06       Impact factor: 4.929

8.  Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.

Authors:  Christine H Chung; Stuart Wong; K Kian Ang; Elizabeth H Hammond; Adam P Dicker; Paul M Harari; Quynh-Thu Le
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007       Impact factor: 7.038

9.  Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.

Authors:  Michael Skwarski; Daniel R McGowan; Elizabeth Belcher; Francesco Di Chiara; Dionisios Stavroulias; Mark McCole; Jennifer L Derham; Kwun-Ye Chu; Eugene Teoh; Jagat Chauhan; Dawn O'Reilly; Benjamin H L Harris; Philip S Macklin; Joshua A Bull; Marcus Green; Gonzalo Rodriguez-Berriguete; Remko Prevo; Lisa K Folkes; Leticia Campo; Petra Ferencz; Paula L Croal; Helen Flight; Cathy Qi; Jane Holmes; James P B O'Connor; Fergus V Gleeson; W Gillies McKenna; Adrian L Harris; Daniel Bulte; Francesca M Buffa; Ruth E Macpherson; Geoff S Higgins
Journal:  Clin Cancer Res       Date:  2021-02-17       Impact factor: 12.531

10.  Hypoxia in head and neck squamous cell carcinoma.

Authors:  John Zenghong Li; Wei Gao; Jimmy Yu-Wai Chan; Wai-Kuen Ho; Thian-Sze Wong
Journal:  ISRN Otolaryngol       Date:  2012-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.